Simcere Pharmaceutical Group Limited (Simcere Pharma) announced plans to revise its existing Articles of Association to strengthen shareholder protections and introduce greater corporate flexibility.
The board proposes three core changes: 1. Alignment with the Hong Kong Stock Exchange’s Core Shareholder Protection Standards, enabling shareholders to attend general meetings virtually and vote electronically. 2. Authorisation for the Company to hold treasury shares, matching the amended Hong Kong Companies Ordinance that permits listed firms to repurchase and keep their own shares. 3. A series of housekeeping updates to streamline governance provisions.
The amendments will be consolidated into a new set of amended and restated Articles of Association. Adoption of the new Articles requires shareholder approval by special resolution at the forthcoming annual general meeting. A detailed circular and AGM notice will be distributed to shareholders electronically in due course.
As of the announcement date (25 March 2026), the Board comprises eight directors, including Chairman and Executive Director Ren Jinsheng, three additional executive directors, and four independent non-executive directors.
Comments